U
Vyome Holdings, Inc. HIND
$5.14 -$0.16-3.02% NASDAQ
Recommendation
Prev Close
$5.30
Volume
74,583
Avg Vol (90D)
--
Market Cap
$29.50M
Dividend & Yield
--
52-Week Range
$4.71 - $16.00
P/E (TTM)
--
EPS (TTM)
--
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Vyome Holdings (HIND, $5.51) Aroon Indicator entered a Downtrend on October 03, 2025.
10/4/2025 - Tickeron - Stocks
Vyome Holdings (HIND, $5.36) Aroon Indicator entered a Downtrend on October 02, 2025.
10/3/2025 - Tickeron - Stocks
Vyome Holdings (HIND, $5.5) Aroon Indicator entered a Downtrend on October 01, 2025.
10/2/2025 - Tickeron - Stocks
HIND: Maxim Group Upgrades Vyome Holdings with New Price Target HIND Stock News
10/2/2025 - GuruFocus
Vyome Holdings upgraded to Buy at Maxim on immuno-inflammatory pipeline
10/2/2025 - The Fly
Vyome Holdings just upgraded at Maxim, here's why
10/2/2025 - The Fly
Vyome Holdings (HIND, $5.18) Aroon Indicator entered a Downtrend on September 30, 2025.
10/1/2025 - Tickeron - Stocks
Vyome Holdings (HIND, $5.36) Aroon Indicator entered a Downtrend on September 29, 2025.
9/30/2025 - Tickeron - Stocks
Vyome Holdings Acquires MIT AI Spinout Oculo Health
9/29/2025 - GuruFocus
Vyome Holdings acquires MIT AI spinout Oculo Health
9/29/2025 - The Fly
Vyome Holdings Acquires MIT AI Spinout Oculo Health
9/29/2025 - Business Wire
Vyome Holdings (HIND, $5.17) Aroon Indicator entered a Downtrend on September 26, 2025.
9/27/2025 - Tickeron - Stocks
Vyome Holdings (HIND, $5.41) Aroon Indicator entered a Downtrend on September 25, 2025.
9/26/2025 - Tickeron - Technical Analysis
Vyome Holdings (HIND, $5.46) Aroon Indicator entered a Downtrend on September 24, 2025.
9/25/2025 - Tickeron - Stocks
Vyome Holdings (HIND) Reveals Promising Preclinical Results for Uveitis Treatment
9/17/2025 - GuruFocus
Vyome Holdings presents results from VT-1908 preclinical studies
9/17/2025 - The Fly
Vyome Presents Strong Data Showing Topical VT-1908 is an Effective Treatment for Uveitis, Opening Up a $3B Addressable Market Opportunity
9/17/2025 - Business Wire
Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies
9/9/2025 - GuruFocus
Vyome Holdings appoints Richard Fahrner as CTO
9/9/2025 - TipRanks Financial Blog
Vyome Holdings appoints Richard Fahrner as CTO
9/9/2025 - The Fly
Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies
9/9/2025 - Business Wire
Vyome Holdings Announces Positive Interim Data from Phase 2 Study of VT-1953 in Malignant ...
9/4/2025 - GuruFocus
Vyome Holdings announces positive interim data from VT-1953 Phase 2 study
9/4/2025 - The Fly
Vyome Holdings Announces Positive Interim Data from Phase 2 Study of VT-1953 in Malignant Fungating Wounds (MFW) and Provides Update on MFW market opportunity
9/4/2025 - Business Wire
Vyome Holdings (HIND, $8.54) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 2, 2025
9/3/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$394.50K
EBITDA (TTM)
-$931.50K
EBIT (TTM)
-$946.30K
Net Income (TTM)
-$1.34M
Balance Sheet
Total Assets (Q)
$1.63M
Total Debt (Q)
$4.51M
Total Liabilities (Q)
$6.62M
Book Value Per Share (Q)
--
Cash Flow
Cash from Operations (TTM)
-$877.50K
Cash from Investing (TTM)
$1.80K
Cash from Financing (TTM)
$1.11M
Net Change in Cash (TTM)
$234.30K
Filings
Filing Date
Tuesday, September 2, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Dec 1 and 5 (est)
Price History
Loading...
Beta
--
7-Day Total Return
-2.10%
30-Day Total Return
-39.92%
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
-63.29%
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Oct 14, 2025 - $4.71
52-week High
Aug 15, 2025 - $16.00
Valuation
Market Cap
$29.50M - Nano Cap
Enterprise Value
$33.62M
Price/Sales (TTM)
--
Price/Book (Q)
--
Dividends and Shares
Shares Outstanding
--
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.vyometx.com
Phone Number
973-832-8147
Address
Harvard Square
One Mifflin Place - Suite 400
Cambridge, MA 02138
Country
United States
Year Founded
2017
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was... more
NASDAQ 10/15/2025 10:45AM Eastern Quotes delayed